Xeltis’ RestoreX technology platform won Gold for Testing & Treatment Options at the 2017 Edison Awards Gala in New York City Thursday night. The global awards recognize persistence and excellence in innovation and are at their 30th edition.
The RestoreX proprietary technology platform is truly disruptive in cardiovascular treatment, the jury concludes. Xeltis’ heart valves and blood vessels enable the patient’s body to naturally restore a new heart valve or blood vessel before being absorbed in the body.
“We are honored the Edison Award recognized the truly innovative potential of our technology. We are making happen something that sounded impossible: enabling the body to restore its own heart valves and patients to live better lives soon,” Xeltis CEO Laurent Grandidier said.
Learn more about the Gold-winning Edison Award RestoreX technology here.
(Source: press release Xeltis)
“Xeltis is truly disruptive in cardiovascular treatment”,